NeonMind Biosciences Inc (6UF0) Financial Statements
NeonMind Biosciences Inc Financial Overview
NeonMind Biosciences Inc's market cap is currently $1.05M. The company's EPS TTM is $-0.01; its P/E ratio is -1.33; NeonMind Biosciences Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 25 | Jun 24 | Mar 24 | Feb 23 | Feb 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -1.33M | $ -1.06M | ― | $ -1.75M | $ -7.83M |
| EBITDA | $ -1.58M | $ 403.40K | ― | $ -1.75M | $ -7.83M |
| Net Income | $ -1.75M | $ -1.54M | ― | $ -2.03M | $ -7.21M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 206.03K | $ 13.98K | $ 135.40K | $ 69.91K | $ 967.27K |
| Total Assets | $ 1.09M | $ 91.12K | $ 719.33K | $ 129.43K | $ 1.34M |
| Total Debt | $ 1.14M | $ 1.19M | $ 1.04M | $ 846.94K | $ 450.01K |
| Net Debt | $ 963.54K | $ 1.19M | $ 984.93K | $ 811.12K | $ -323.52K |
| Total Liabilities | $ 1.74M | $ 2.00M | $ 1.33M | $ 1.53M | $ 1.05M |
| Stockholders' Equity | $ -635.18K | $ -1.90M | $ -612.89K | $ -1.40M | $ 290.30K |
| Cash Flow | |||||
| Free Cash Flow | $ -988.65K | $ -89.79K | $ -1.31M | $ -1.22M | $ -5.82M |
| Operating Cash Flow | $ -988.66K | $ -89.79K | $ -1.13M | $ -1.08M | $ -5.82M |
| Investing Cash Flow | $ -129.42K | $ 37.60K | $ -36.15K | $ 72.14K | $ 389.12K |
| Financing Cash Flow | $ 1.29M | $ 0.00 | $ 627.93K | $ 271.00K | $ 6.20M |
Currency in CAD
